References
- Brunet J F, Denizot F, Luciani M F, Roux-Dosseto M, Suzan M, Mattei M G, Golstein P. A new member of the immunoglobulin superfamily—CTLA-4. Nature 1987; 328(6127):267–270. [PUBMED], [INFOTRIEVE]
- Linsley P S, Brady W, Urnes M, Grosmaire L S, Damle N K, Ledbetter J A. CTLA-4 is a second receptor for the B cell activation antigen B7. J Exp Med 1991; 174(3):561–569. [PUBMED], [INFOTRIEVE]
- Krummel M F, Allison J P. CTLA-4 engagement inhibits IL-2 accumulation and cell cycle progression upon activation of resting T cells. J Exp Med 1996; 183(6):2533–2540. [PUBMED], [INFOTRIEVE]
- Saverino D, Tenca C, Zarcone D, Merlo A, Megiovanni A M, Valle M T, Manca F, Grossi C E, Ciccone E. CTLA-4 (CD152) inhibits the specific lysis mediated by human cytolytic T lymphocytes in a clonally distributed fashion. J Immunol 1999; 162(2):651–658. [PUBMED], [INFOTRIEVE]
- Carreno B M, Bennett F, Chau T A, Ling V, Luxenberg D, Jussif J, Baroja M L, Madrenas J. CTLA-4 (CD152) can inhibit T cell activation by two different mechanisms depending on its level of cell surface expression. J Immunol 2000; 165(3):1352–1356. [PUBMED], [INFOTRIEVE]
- Waterhouse P, Penninger J M, Timms E, Wakeham A, Shahinian A, Lee K P, Thompson C B, Griesser H, Mak T W. Lymphoproliferative disorders with early lethality in mice deficient in CTLA-4. Science 1995; 270(5238):985–988. [PUBMED], [INFOTRIEVE]
- Wardlaw A J, Brightling C E, Green R, Woltmann G, Bradding P, Pavord I D. New insights into the relationship between airway inflammation and asthma. Clin Sci (Lond) 2002; 103(2):201–211. [CSA]
- Tattersfield A E, Knox A J, Britton J R, Hall I P. Asthma. Lancet 2002; 360(9342):1313–1322. [PUBMED], [INFOTRIEVE]
- Burr J S, Kimzey S L, Randolph D R, Green J M. CD28 and CTLA4 coordinately regulate airway inflammatory cell recruitment and T-helper cell differentiation after inhaled allergen. Am J Respir Cell Mol Biol 2001; 24(5):563–568. [PUBMED], [INFOTRIEVE], [CSA]
- Krinzman S J, De Sanctis G T, Cernadas M, Mark D, Wang Y, Listman J, Kobzik L, Donovan C, Nassr K, Katona I, Christiani D C, Perkins D L, Finn P W. Inhibition of T cell costimulation abrogates airway hyperresponsiveness in a murine model. J Clin Invest 1996; 98(12):2693–2699. [PUBMED], [INFOTRIEVE], [CSA]
- Deurloo D T, van Esch B C, Hofstra C L, Nijkamp F P, van Oosterhout A J. CTLA4-IgG reverses asthma manifestations in a mild but not in a more “severe” ongoing murine model. Am J Respir Cell Mol Biol 2001; 25(6):751–760., [PUBMED], [INFOTRIEVE], [CSA]
- Magistrelli G, Jeannin P, Herbault N, Benoit De Coignac A, Gauchat J F, Bonnefoy J Y, Delneste Y. A soluble form of CTLA-4 generated by alternative splicing is expressed by nonstimulated human T cells. Eur J Immunol 1999; 29(11):3596–3602. [PUBMED], [INFOTRIEVE], [CSA]
- Oaks M K, Hallett K M. A soluble form of CTLA-4 in patients with autoimmune thyroid disease. J Immunol 2000; 164(10):5015–5018. [PUBMED], [INFOTRIEVE]
- Lee S Y, Lee Y H, Shin C, Shim J J, Kang K H, Yoo S H, In K H. Association of asthma severity and bronchial hyperresponsiveness with a polymorphism in the cytotoxic T-lymphocyte antigen-4 gene. Chest 2002; 122(1):171–176. [PUBMED], [INFOTRIEVE]
- Aas K. Heterogeneity of bronchial asthma. Sub-populations-or different stages of the disease. Allergy 1981; 36(1):3–14. [PUBMED], [INFOTRIEVE]
- Shi H Z, Xiao C Q, Zhong D, Qin S M, Liu Y, Liang G R, Xu H, Chen Y Q, Long X M, Xie Z F. Effect of inhaled interleukin-5 on airway hyperreactivity and eosinophilia in asthmatics. Am J Respir Crit Care Med 1998; 157(1):204–209. [PUBMED], [INFOTRIEVE], [CSA]
- Kay A B. Allergy and allergic diseases: first of two parts. N Engl J Med 2001; 344(1):30–37. [PUBMED], [INFOTRIEVE], [CSA]
- Schwartz R H. A cell culture model for T lymphocyte clonal anergy. Science 1990; 248(4961):1349–1356. [PUBMED], [INFOTRIEVE]
- June C H, Bluestone J A, Nadler L M, Thompson C B. The B7 and CD28 receptor families. Immunol. Today 1994; 15(7):321–331. [PUBMED], [INFOTRIEVE], [CSA]
- Walunas T L, Lenschow D J, Bakker C Y, Linsley P S, Freeman G J, Green J M, Thompson C B, Bluestone J A. CTLA-4 can function as a negative regulator of T cell activation. Immunity 1994; 1(5):405–413. [PUBMED], [INFOTRIEVE], [CSA]
- Keane-Myers A, Gause W C, Linsley P S, Chen S J, Wills-Karp M. B7-CD28/CTLA-4 costimulatory pathways are required for the development of T helper cell 2-mediated allergic airway responses to inhaled antigens. J Immunol 1997; 158(5):2042–2049. [PUBMED], [INFOTRIEVE]
- Masteller E L, Chuang E, Mullen A C, Reiner S L, Thompson C B. Structural analysis of CTLA-4 function in vivo. J Immunol 2000; 164(10):5319–5327. [PUBMED], [INFOTRIEVE]
- Oaks M K, Hallett K M, Penwell R T, Stauber E C, Warren S J, Tector A J. A native soluble form of CTLA-4. Cell Immunol 2000; 201(2):144–153. [PUBMED], [INFOTRIEVE], [CSA]